NSD2 and metastatic prostate carcinoma: In particular, we have demonstrated that the Nuclear receptor binding SET Domain Protein 2 (NSD2) is a robust marker of lethal metastatic prostate cancer and a key driver of prostate cancer metastasis, extending previous studies that have reported the relevance of NSD2 in prostate cancer49–51.